代谢：异柠檬酸脱氢酶2（IDH2）在体内驱动癌症发展。 - Suppr

Metabolism: IDH2 drives cancer in vivo.

作者信息

Lokody Isabel

出版信息

Nat Rev Cancer. 2013 Nov;13(11):756-7. doi: 10.1038/nrc3619. Epub 2013 Oct 17.

DOI:10.1038/nrc3619

PMID:24132108

Abstract

摘要

相似文献

Metabolism: IDH2 drives cancer in vivo.

Nat Rev Cancer. 2013 Nov;13(11):756-7. doi: 10.1038/nrc3619. Epub 2013 Oct 17.

Anticancer drugs: IDH2 drives cancer in vivo.

Nat Rev Drug Discov. 2013 Nov;12(11):826-7. doi: 10.1038/nrd4160.

Induction of sarcomas by mutant IDH2.

Genes Dev. 2013 Sep 15;27(18):1986-98. doi: 10.1101/gad.226753.113.

[I. Identification of a Possible Therapeutic Target for Chondrosarcoma with IDH Mutant Inhibitors].

Gan To Kagaku Ryoho. 2017 Mar;44(3):212-216.

Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.

Hum Pathol. 2017 Jul;65:239-246. doi: 10.1016/j.humpath.2017.05.015. Epub 2017 May 25.

Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesis.

Curr Opin Oncol. 2014 Jul;26(4):403-7. doi: 10.1097/CCO.0000000000000092.

The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.

Am Soc Clin Oncol Educ Book. 2015:e648-55. doi: 10.14694/EdBook_AM.2015.35.e648.

IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.

Histopathology. 2012 Jan;60(2):363-5. doi: 10.1111/j.1365-2559.2011.04010.x. Epub 2011 Nov 10.

CORR Insights®: Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?

Clin Orthop Relat Res. 2024 Jun 1;482(6):957-959. doi: 10.1097/CORR.0000000000003019. Epub 2024 Mar 6.

A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.

Biochem Biophys Res Commun. 2015 Apr 17;459(4):636-42. doi: 10.1016/j.bbrc.2015.02.162. Epub 2015 Mar 6.

引用本文的文献

Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease.

Metabolites. 2022 Jan 7;12(1):46. doi: 10.3390/metabo12010046.

Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.

Cancer Biol Med. 2016 Jun;13(2):248-59. doi: 10.20892/j.issn.2095-3941.2016.0023.

Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7.

Tumour Biol. 2016 Apr;37(4):5225-30. doi: 10.1007/s13277-015-4358-2. Epub 2015 Nov 10.

Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis.

Sci Rep. 2015 Oct 13;5:15217. doi: 10.1038/srep15217.

Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers.

Biomed Res Int. 2014;2014:364625. doi: 10.1155/2014/364625. Epub 2014 Jun 5.

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.

J Exp Clin Cancer Res. 2014 Apr 10;33(1):32. doi: 10.1186/1756-9966-33-32.

本文引用的文献

Induction of sarcomas by mutant IDH2.

Genes Dev. 2013 Sep 15;27(18):1986-98. doi: 10.1101/gad.226753.113.

Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.

Genes Dev. 2013 Sep 15;27(18):1974-85. doi: 10.1101/gad.226613.113.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Metabolism: IDH2 drives cancer in vivo.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献